NO962826D0 - Ribozymer som målsöker retroviral pakkende sekvensekspersjons-konstruksjoner og rekombinante retroviruser som inneholder slike konstruksjoner - Google Patents
Ribozymer som målsöker retroviral pakkende sekvensekspersjons-konstruksjoner og rekombinante retroviruser som inneholder slike konstruksjonerInfo
- Publication number
- NO962826D0 NO962826D0 NO962826A NO962826A NO962826D0 NO 962826 D0 NO962826 D0 NO 962826D0 NO 962826 A NO962826 A NO 962826A NO 962826 A NO962826 A NO 962826A NO 962826 D0 NO962826 D0 NO 962826D0
- Authority
- NO
- Norway
- Prior art keywords
- constructs
- compound
- recombinant retroviruses
- packaging sequence
- sequence expression
- Prior art date
Links
- 102000053642 Catalytic RNA Human genes 0.000 title abstract 2
- 108090000994 Catalytic RNA Proteins 0.000 title abstract 2
- 108091092562 ribozyme Proteins 0.000 title abstract 2
- 238000004806 packaging method and process Methods 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- 241001430294 unidentified retrovirus Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 230000035897 transcription Effects 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/178,082 US5712384A (en) | 1994-01-05 | 1994-01-05 | Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| US08/310,259 US6114167A (en) | 1994-01-05 | 1994-09-21 | Ribozymes targeting the MoMLV PSI packaging sequence and the HIV tat sequence |
| PCT/IB1995/000050 WO1995018854A1 (en) | 1994-01-05 | 1995-01-05 | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO962826D0 true NO962826D0 (no) | 1996-07-04 |
| NO962826L NO962826L (no) | 1996-08-27 |
| NO319376B1 NO319376B1 (no) | 2005-07-25 |
Family
ID=26873946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19962826A NO319376B1 (no) | 1994-01-05 | 1996-07-04 | Ribozymer som malsoker retrovirale pakkende sekvensekresjons-konstruksjoner, transfer vektor, celle innbefattende en ribozymsekvens, human celle resistent mot HIV-infeksjon, og en farmasoytisk sammensetning. |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP0753062A4 (no) |
| JP (1) | JP3691849B2 (no) |
| CN (1) | CN1267552C (no) |
| AT (1) | ATE320487T1 (no) |
| AU (1) | AU698730B2 (no) |
| CA (1) | CA2180358A1 (no) |
| DE (1) | DE69534864T2 (no) |
| DK (1) | DK1298208T3 (no) |
| ES (1) | ES2260376T3 (no) |
| IL (1) | IL112261A (no) |
| NO (1) | NO319376B1 (no) |
| NZ (1) | NZ278432A (no) |
| PT (1) | PT1298208E (no) |
| WO (1) | WO1995018854A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020058636A1 (en) * | 1994-09-21 | 2002-05-16 | Geoffrey P. Symonds | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| EP0865282A4 (en) * | 1995-08-25 | 2002-01-16 | Univ California | Chimeric antiviral agents that contain REV-binding nucleic acids |
| US5888767A (en) | 1996-11-27 | 1999-03-30 | The Johns Hopkins University School Of Medicine | Method of using a conditionally replicating viral vector to express a gene |
| EP0871757B1 (en) * | 1995-11-28 | 2003-03-12 | The Johns Hopkins University School Of Medicine | Conditionally replicating viral vectors and their use |
| US6776986B1 (en) | 1996-06-06 | 2004-08-17 | Novartis Ag | Inhibition of HIV-1 replication by antisense RNA expression |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| ATE526406T1 (de) | 1998-03-20 | 2011-10-15 | Commw Scient Ind Res Org | Kontrolle der genexpression |
| EP1147204A1 (en) | 1999-01-28 | 2001-10-24 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
| US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
| CA2369944A1 (en) | 2001-01-31 | 2002-07-31 | Nucleonics Inc. | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
| US7345025B2 (en) | 2001-07-10 | 2008-03-18 | Johnson & Johnson Research Pty. Limited | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| US7994144B2 (en) | 2001-07-10 | 2011-08-09 | Johnson & Johnson Research Pty, Limited | Process for the preparation of a composition of genetically modified hematopoietic progenitor cells |
| CN102841007A (zh) * | 2012-09-05 | 2012-12-26 | 福建省农业科学院畜牧兽医研究所 | 一种便于鸭精子计数的精液稀释液及其使用方法 |
| CN113549641B (zh) * | 2021-06-29 | 2023-12-22 | 复旦大学 | 一种核酶介导的多顺反子载体及其构建方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225337A (en) * | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Ribozyme compositions and methods for use |
| CA2107789A1 (en) * | 1991-04-05 | 1992-10-06 | Thomas E. Wagner | Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences |
| CA2154363A1 (en) * | 1993-01-22 | 1994-08-04 | Bruce A. Sullenger | Localization of therapeutic agents |
| IL108719A0 (en) * | 1993-02-25 | 1994-08-26 | Ortho Pharma Corp | Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviralvectors and recombinant retroviruses containing them |
| WO1995004818A1 (en) * | 1993-08-06 | 1995-02-16 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting human immunodeficiency virus replication |
-
1995
- 1995-01-05 IL IL11226195A patent/IL112261A/xx not_active IP Right Cessation
- 1995-01-05 ES ES02025406T patent/ES2260376T3/es not_active Expired - Lifetime
- 1995-01-05 PT PT02025406T patent/PT1298208E/pt unknown
- 1995-01-05 EP EP95905220A patent/EP0753062A4/en not_active Withdrawn
- 1995-01-05 AT AT02025406T patent/ATE320487T1/de not_active IP Right Cessation
- 1995-01-05 NZ NZ278432A patent/NZ278432A/en not_active IP Right Cessation
- 1995-01-05 DK DK02025406T patent/DK1298208T3/da active
- 1995-01-05 WO PCT/IB1995/000050 patent/WO1995018854A1/en not_active Application Discontinuation
- 1995-01-05 AU AU13912/95A patent/AU698730B2/en not_active Ceased
- 1995-01-05 EP EP02025406A patent/EP1298208B1/en not_active Expired - Lifetime
- 1995-01-05 JP JP51840395A patent/JP3691849B2/ja not_active Expired - Fee Related
- 1995-01-05 DE DE69534864T patent/DE69534864T2/de not_active Expired - Lifetime
- 1995-01-05 CA CA002180358A patent/CA2180358A1/en not_active Abandoned
- 1995-01-05 CN CNB951919318A patent/CN1267552C/zh not_active Expired - Fee Related
-
1996
- 1996-07-04 NO NO19962826A patent/NO319376B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3691849B2 (ja) | 2005-09-07 |
| EP1298208A3 (en) | 2004-01-07 |
| NO962826L (no) | 1996-08-27 |
| CN1145638A (zh) | 1997-03-19 |
| DK1298208T3 (da) | 2006-07-24 |
| AU1391295A (en) | 1995-08-01 |
| AU698730B2 (en) | 1998-11-05 |
| CA2180358A1 (en) | 1995-07-13 |
| PT1298208E (pt) | 2006-10-31 |
| EP0753062A4 (en) | 1999-10-20 |
| DE69534864D1 (de) | 2006-05-11 |
| ATE320487T1 (de) | 2006-04-15 |
| CN1267552C (zh) | 2006-08-02 |
| IL112261A0 (en) | 1995-03-30 |
| NO319376B1 (no) | 2005-07-25 |
| DE69534864T2 (de) | 2007-02-22 |
| ES2260376T3 (es) | 2006-11-01 |
| IL112261A (en) | 2005-08-31 |
| WO1995018854A1 (en) | 1995-07-13 |
| EP0753062A1 (en) | 1997-01-15 |
| EP1298208B1 (en) | 2006-03-15 |
| JPH09508004A (ja) | 1997-08-19 |
| NZ278432A (en) | 1998-06-26 |
| EP1298208A2 (en) | 2003-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO962826L (no) | Ribozymer som målsöker retroviral pakkende sekvensekspersjons-konstruksjoner og rekombinante retroviruser som inneholder slike konstruksjoner | |
| KR960703170A (ko) | 안티센스 올리고뉴클레오티드 및 인간면역결핍바이러스감염에서 그것의 치료적이용(antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection) | |
| CY1112430T1 (el) | Λεντινοϊικο τριπλο dνα και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dνα | |
| NO981944L (no) | Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav | |
| FI946201A (fi) | Itsestabiloidut oligonukleotidit terapeuttisina aineina | |
| ES2167905T3 (es) | Composiciones herbicidas. | |
| AU6871398A (en) | Method for enhancing expression of a foreign or endogenous gene product in pla nts | |
| ATE141946T1 (de) | Hiv-2-virusvarianten | |
| ATE340864T1 (de) | Retrovirale vektoren | |
| DK1025237T3 (da) | Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder | |
| DK0630409T3 (da) | Defekt-pakkende ikke-onkovirus-vektorer baseret på MPMV | |
| DK1175489T3 (da) | Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider | |
| DK1908772T3 (da) | Polypeptider og polynucleinsyrer af phorphorymonas gingivalis | |
| BR9407693A (pt) | Sequência nucleotídica vetor composiçao farmacêutica utilizaçao do vetor e de um composto | |
| PT811071E (pt) | Sequencias amolificadas derivadas do gene da desmina vectores que compreendem estas sequencias e suas utilizacoes para a producao de proteinas | |
| DE60043870D1 (de) | Auf bovinem Immundefizienvirus (BIV) basierende Vektoren | |
| NO995858L (no) | Ny klasse kationiske nukleinsyre-overføringsmidler | |
| FR2829498B1 (fr) | Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins | |
| HUP0203518A2 (en) | Gene therapy of hiv-positive patients by expression of membrane-anchored gp41 peptides | |
| CA2167630A1 (en) | cDNA of DOCK180 Gene and DOCK180 Protein | |
| WO2004024190A3 (en) | Recombinant lentivirale vector pseudotyped with the hemagglutinin protein for gene transfer into the retina | |
| MX9708943A (es) | Genes de polifenol oxidasa de la lengua y platano. | |
| FR2721617B1 (fr) | Fragments d'acides nucléiques, dérivés du génome de Mycobacterium xenopi et leurs applications. | |
| WO2004003209A3 (fr) | Acide nucleique isole du 5'ntr du gene fgf-1 humain presentant une activite ires | |
| NO945020L (no) | Selv-stabiliserende oligonukleotider som terapeutiske midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |